Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families

被引:13
作者
de Snoo, Femke A. [1 ,2 ]
Hottenga, Jouke-Jan [3 ]
Gillanders, Elizabeth M. [4 ]
Sandkuijl, Loudewijk A. [5 ]
Jones, Mary Pat [4 ]
Bergman, Wilma [6 ]
van der Drift, Clasine [6 ]
van Leeuwen, Inge [6 ]
van Mourik, Lenny [1 ,2 ]
ter Huurne, Jeanet A. C. [1 ,2 ]
Frants, Rune R. [1 ,2 ]
Willemze, Rein [6 ]
Breuning, Martijn H. [1 ,2 ]
Trent, Jeffrey M. [7 ]
Gruis, Nelleke A. [3 ]
机构
[1] Leiden Univ, Med Ctr, Dept Human, NL-2333 ZA Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands
[3] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands
[4] NHGRI, Inherited Dis Res Branch, NIH, Dept Hlth & Human Serv, Baltimore, MD USA
[5] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands
[6] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands
[7] Translat Genom Res Inst, Phoenix, AZ USA
关键词
nevus gene; familial melanoma; linkage;
D O I
10.1038/ejhg.2008.72
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In most Dutch melanoma families, a founder deletion in the melanoma susceptibility gene CDKN2A (which encodes p16) is present. This founder deletion (p16-Leiden) accounts for a significant proportion of the increased melanoma risk. However, it does not account for the Atypical Nevus (AN) phenotype that segregates in both p16-Leiden carriers and non-carriers. The AN-affected p16-Leiden family members are therefore a unique valuable resource for unraveling the genetic etiology of the AN phenotype, which is considered both a risk factor and a precursor lesion for melanoma. In this study, we performed a genome-wide scan for linkage in four p16-Leiden melanoma pedigrees, classifying family members with five or more AN as affected. The strongest evidence for an atypical nevus susceptibility gene was mapped to chromosome band 7q21.3 (two-point LOD score 2.751), a region containing candidate gene CDK6.
引用
收藏
页码:1135 / 1141
页数:7
相关论文
共 26 条
  • [1] GRR: graphical representation of relationship errors
    Abecasis, GR
    Cherny, SS
    Cookson, WOC
    Cardon, LR
    [J]. BIOINFORMATICS, 2001, 17 (08) : 742 - 743
  • [2] Bishop DT, 2002, J NATL CANCER I, V94, P894, DOI 10.1093/jnci/94.12.894
  • [3] Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations
    Bishop, JAN
    Wachsmuth, RC
    Harland, M
    Bataille, V
    Pinney, E
    Mack, P
    Baglietto, L
    Cuzick, J
    Bishop, DT
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (01) : 28 - 33
  • [4] CANNONALBRIGHT LA, 1994, CANCER RES, V54, P6041
  • [5] Cramer SF, 2001, AM J DERMATOPATH, V23, P160, DOI 10.1097/00000372-200104000-00016
  • [6] An integrated genetic map for linkage analysis
    Duffy, DL
    [J]. BEHAVIOR GENETICS, 2006, 36 (01) : 4 - 6
  • [7] GENETIC SUSCEPTIBILITY TO NEVI - A TWIN STUDY
    EASTON, DF
    COX, GM
    MACDONALD, AM
    PONDER, BAJ
    [J]. BRITISH JOURNAL OF CANCER, 1991, 64 (06) : 1164 - 1167
  • [8] Genome-wide search for nevus density shows linkage to two melanoma loci on chromosome 9 and identifies a new QTL on 5q31 in an adult twin cohort
    Falchi, Mario
    Spector, Tim D.
    Perks, Ursula
    Kato, Bernet S.
    Bataille, Veronique
    [J]. HUMAN MOLECULAR GENETICS, 2006, 15 (20) : 2975 - 2979
  • [9] The CDKN2A (p16) gene and human cancer
    Foulkes, WD
    Flanders, TY
    Pollock, PM
    Hayward, NK
    [J]. MOLECULAR MEDICINE, 1997, 3 (01) : 5 - 20
  • [10] Prospective risk of cancer in CDKN2A germline mutation carriers
    Goldstein, AM
    Struewing, JP
    Fraser, MC
    Smith, MW
    Tucker, MA
    [J]. JOURNAL OF MEDICAL GENETICS, 2004, 41 (06) : 421 - 424